Allogene Therapeutics
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
210 E Grand Ave, South San Francisco, Ca...Phone Number
(650) 457-2700Website
www.allogene.comRevenue
$47.8 MillionStock Symbol
ALLOIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Allogene Therapeutics
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibodRead more
Allogene Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allogene Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Allogene Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Allogene Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Allogene Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Allogene Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Allogene Therapeutics
Earning: See what the market has to say on Allogene Therapeutics recently announced quarterly report
Check out if Allogene Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Allogene Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Allogene Therapeutics
Compare insights from companies similar to Allogene Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Allogene Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allogene Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allogene Therapeutics.
Allogene Therapeutics financials insights
Gather financial insights about Allogene Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Multiple Rounds
$708M
2026
Stock/Share Issuance
$200M
Allogene Therapeutics Tech Stack
A closer look at the technologies used by Allogene Therapeutics
Most Recent Scoops
Promotion
Executive Move
Executive Moves, Promotion, Board of Directors
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Open Position
Open Position
Open Position
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Allogene Therapeutics
Sign Up For FreeTo access detailed company insights
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult pati... Read More
